Author:
Asghar Laila F. A.,Chure Chetan B.,Chandran Sajeev
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference56 articles.
1. Hull MA, Gardner SH, Hawcroft G. Activity of the non-steroidal anti- inflammatory drug indomethacin against colorectal cancer. Cancer Treat Rev. 2003;29:309–20.
2. Mandayam S, Huang R, Tarnawski AS, Chiou SK. Roles of survivin isoforms in the chemopreventive actions of NSAIDS on colon cancer cells. Apoptosis. 2007;12:1109–16.
3. Kapitanovi S, Čačev T, Antica M, Kralj M, Cavri G, Krešimir P, et al. Effect of indomethacin on E-cadherin and β-catenin expression in HT-29 colon cancer cells. Exp Mol Pathol. 2006;80:91–6.
4. Fujino H, Chen XB, Regan JW, Murayama T. Indomethacin decreases EP2 prostanoid receptor expression in colon cancer cells. Biochem Biophys Res Commun. 2007;359(3):568–73.
5. Goodman GA, Goodman LS. Analgesics-antipyretics; pharmacotherapy of gout. In: Brunton, editor. The pharmacological basis of therapeutics, 11th edn. New York: Mcgraw Hill; 2006. p. 699–700.